Iron(III)Hydroxide Polymaltose + Folic Acid Syrup
Iron(III)Hydroxide Polymaltose Complex IP 50mg + Folic Acid IP 0.5mg Oral Syrup · Haematology, Nutraceuticals, General Wellness
WHO-GMP
DCGI Approved
Baddi, HP
Active Pharma Composition
SYRUP PRESENTATION:
Each 15 ml contains:
Iron(III)Hydroxide Polymaltose Complex IP
50 mg
Folic Acid IP
0.5 mg
Flavoured Syrupy Base
q.s.
Product Data Sheet
Segments & Ranges
Syrups / Oral Liquids
Dosage Form
Oral Syrup
Pharma Class
Haematology / Nutraceuticals / General Wellness
Pack Sizes
200 ml / 300 ml
Storage Condition
Store below 30°C in a cool, dry place. Protect from direct sunlight. Keep tightly closed.
Stability / Shelf Life
24 Months
Manufacturing Location
Baddi, Himachal Pradesh
Compliance
DCGI Approved / Schedule M
Flavor Options
Chocolate and Orange — preferred for iron supplements
Pack Options
200ml & 300ml — sticker label, metallic label, drip-off embossed carton, measuring cap, printed cap, with/without carton
Batch Size
5,000 to 2,00,000+ Units
Schedule M Compliant
Private Label Ready
Pan-India Dispatch
WHO-GMP
ISO 9001:2015
GLP Certified
DCGI Approved
Schedule M
Product Profile
Iron(III)Hydroxide Polymaltose Complex + Folic Acid Syrup is a gentle iron supplement indicated for iron deficiency anaemia. As a premier WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech manufactures this syrup with validated two-API quality control.
DCGI Approved
Comprehensive documentation and CDSCO support for rapid market entry in India.
Fast Turnaround
30-45 days lead time for new batches with state-of-the-art logistics.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Description & Therapeutic Class
This syrup belongs to the Syrups category within the Haematology and Nutraceuticals therapeutic segments.
Saar Biotech manufactures this syrup from our manufacturing facility in Baddi.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
The Saar Biotech Advantage
At Saar Biotech, we manufacture Iron Polymaltose Syrup using a controlled oral syrup manufacturing process that ensures dose uniformity and palatability.
- Two-API Uniformity: Both actives are uniformly distributed for consistent dosing.
- Taste Masking: Chocolate and orange flavours mask the iron taste.
- pH and Stability Management: Both actives remain chemically stable for 24 months.
- 200ml and 300ml Pack Coverage: Suitable for extended treatment courses.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Key Indications & Clinical Use
This syrup is manufactured and supplied by Saar Biotech for the following established clinical indications:
- Iron Deficiency Anaemia: Treatment and prevention
- Nutritional Anaemia: Anaemia due to inadequate dietary iron
- Pregnancy-Related Anaemia: Iron supplementation
- Post-illness Recovery: Nutritional support
Use under physician supervision.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Mechanism of Action & Manufacturing Integrity
Iron(III)Hydroxide Polymaltose releases iron in a controlled manner with high bioavailability. Folic Acid supports red blood cell maturation.
Manufacturing Integrity
- Complex Stability: The iron polymaltose complex remains stable in the syrup.
- Vitamin Stability: Folic acid is protected from degradation.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
B2B & Contract Manufacturing Details
Saar Biotech provides Third-Party Manufacturing for this syrup from our oral liquid manufacturing facility in Baddi, Himachal Pradesh.
- Facility: Oral liquid manufacturing area with controlled processing, automated bottle filling, capping, labelling, and carton packing lines.
- Capacity: Scalable from brand-entry launches to large commercial batches.
- Quality Lab: In-house GLP-certified lab with HPLC/Assay, pH, viscosity, MLT, and fill volume checks.
- Turnaround: New orders — 30 to 45 working days. Repeat orders — 20 to 25 working days.
- Packaging: 200ml and 300ml PET or dark amber bottles; sticker label, metallic label, measuring cup, printed cap.
- MOQ: Starting at 5,000–10,000 units per SKU.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Storage & Handling Guidelines
- Warehouse Conditions: Store below 30°C in a cool, dry environment. Protect from direct sunlight.
- Light Protection: Amber bottles and outer cartons protect from photo-degradation.
- Measuring Cup Use: A calibrated measuring cap ensures accurate dosing.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Quality Control & Compliance
Every commercial batch is quarantined until it passes a comprehensive analytical release protocol:
- Two-API Assay: Quantification of Iron Polymaltose and Folic Acid.
- pH Testing: Verification of pH within stability-appropriate specification range.
- Microbial Limit Testing (MLT): IP-compliant microbiological testing.
- Certificate of Analysis (COA): Issued with every B2B batch.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Safety Profile & Precautions
- Gentle on Stomach: Minimal gastrointestinal side effects.
- Overload Risk: Not for use in haemochromatosis, haemosiderosis.
- Contraindications: Known hypersensitivity to any component.
For third-party manufacturing enquiries, private-label contracts, or to request pricing and packaging options for Iron Polymaltose Syrup, please use the B2B enquiry form below.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Medical Intelligence
Clinical Q&A for Iron(III)Hydroxide Polymaltose + Folic Acid Syrup
Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.
What are the clinical indications for Iron(III)Hydroxide Polymaltose + Folic Acid Syrup?
This syrup is indicated for the treatment and prevention of iron deficiency anaemia, particularly in patients who cannot tolerate conventional iron salts. Iron(III)Hydroxide Polymaltose is a stable macromolecular complex with high bioavailability and minimal gastrointestinal side effects.
What makes Iron Polymaltose different from other iron supplements?
Iron Polymaltose is a non-ionic macromolecular complex that releases iron in a controlled manner. It has significantly fewer gastrointestinal side effects compared to ferrous salts because it is absorbed by a different mechanism. The polymaltose complex ensures high bioavailability with excellent tolerability.
What is the standard dosing protocol?
The standard adult dose is 15 ml taken once or twice daily, or as directed by a physician. For children, dosing should be based on body weight. The syrup should be shaken well before each use. Treatment duration depends on the severity of anaemia.
What are the key precautions for this syrup?
This syrup is contraindicated in patients with known hypersensitivity to any component, haemochromatosis, haemosiderosis, and other iron overload disorders. Caution is advised in patients with gastrointestinal disorders.
What are the common side effects?
Iron Polymaltose is well-tolerated with minimal gastrointestinal side effects. Occasional mild gastrointestinal discomfort may occur. Dark stool is expected and harmless.
Manufacturing Support
B2B Manufacturing Guide for Iron(III)Hydroxide Polymaltose + Folic Acid Syrup
Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.
What pack sizes and packaging options are available for Iron Polymaltose Syrup?
Saar Biotech manufactures Iron(III)Hydroxide Polymaltose Syrup in 200 ml and 300 ml bottle formats. Packaging options include: sticker label, metallic label, drip-off brand embossed carton, measuring cap, printed cap, company-logo printed PP cap, with-carton or without-carton supply.
What is the MOQ for this syrup?
Standard MOQ ranges from 5,000 to 10,000 units per SKU, depending on bottle size, label type, and carton format.
What analytical tests are performed on every manufacturing batch?
Every batch undergoes HPLC/Assay for Iron Polymaltose and Folic Acid content, pH and viscosity testing, and Microbial Limit Testing (MLT). A Certificate of Analysis (COA) is issued.
What is the turnaround time for a new order?
Initial third-party production typically requires 30 to 45 working days following packaging confirmation. Repeat orders are fulfilled in 20–25 working days.
Do you offer private labelling and packaging design?
Yes, our in-house design team provides end-to-end support for private label packaging, including mono-cartons, labels, and promotional materials compliant with regulatory guidelines.
Similar Products
Same Formula
Other high-quality products that use the same effective active ingredients.
